Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?

Di Somma C, Scarano E, Arianna R, Romano F, Lavorgna M, Serpico D, Colao A

Open source

DOI
10.3390/jcm12020662
Published
2023 Jan 13
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm12020662,
  title = {Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?},
  author = {Di Somma C and Scarano E and Arianna R and Romano F and Lavorgna M and Serpico D and Colao A},
  year = {2023},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm12020662},
  url = {https://doi.org/10.3390/jcm12020662}
}

RIS

TY  - JOUR
TI  - Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?
AU  - Di Somma C
AU  - Scarano E
AU  - Arianna R
AU  - Romano F
AU  - Lavorgna M
AU  - Serpico D
AU  - Colao A
PY  - 2023
JO  - Journal of clinical medicine
DO  - 10.3390/jcm12020662
UR  - https://doi.org/10.3390/jcm12020662
ER  - 

APA

C, D. S., E, S., R, A., F, R., M, L., D, S., & A, C. (2023). Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?. Journal of clinical medicine. https://doi.org/10.3390/jcm12020662

Source records